. 2015 Jul 2;34:26. doi: 10.1186/s40880-015-0028-4
© Fang et al. 2015
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Figure 4.
Chemical structures of anti-ALK/ROS1 therapeutic agents. ROS1 c-ros oncogene 1 receptor tyrosine kinase.